What is BENEV?
BENEV Company Inc. operates as a US FDA-registered distributor focused on innovative cosmeceuticals and medical devices, including advanced Exosome treatments and SYLFIRM X RF Microneedling technology. The company's product portfolio also encompasses growth factors and aesthetic injectables, all aimed at enhancing beauty and promoting a vibrant lifestyle. BENEV targets health and beauty professionals, with a strategic objective to expand its global network through integrity and creative business practices. Their core mission revolves around providing solutions that revive, restore, and renew, catering to a broad spectrum of consumer needs.
How much funding has BENEV raised?
BENEV has raised a total of $150K across 1 funding round:
Debt
$150K
Debt (2020): $150K with participation from PPP
Key Investors in BENEV
PPP
Public-Private Partnership
What's next for BENEV?
The substantial capital infusion, particularly the recent strategic investment, positions BENEV for accelerated growth and market expansion. With a focus on late-stage funding, the company is likely to invest in scaling its operations, enhancing its product development pipeline, and broadening its distribution channels globally. This strategic backing suggests a strong investor confidence in BENEV's business model and its potential to capture a larger share of the aesthetic and medical device market. Future initiatives may include further technological advancements and strategic partnerships to solidify its competitive edge.
See full BENEV company page
